Navigation Links
Emerging Pharmaceutical Markets Globally
Date:11/14/2011

NEW YORK, Nov. 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Emerging Pharmaceutical Markets Globally

http://www.reportlinker.com/p0187762/Emerging-Pharmaceutical-Markets-Globally.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

The growth in pharma markets in developing countries with emerging economies (E7 countries) has outpaced the overall growth of the global pharma market. The factors including rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases, and low-cost are driving the pharma markets in these countries with a fast pace. In 2010, pharma market in E7 countries (Brazil, Russia, China, India, Turkey, Mexico, and Indonesia) was estimated at around US$ 136 Billion, and it is expected to achieve a high growth during 2011-2014, thereby increasing their share in global pharma market.

According to our new research study on the sector titled, "Emerging Pharmaceutical Markets Globally", the pharmaceutical market in the abovementioned emerging countries is projected to grow at a double digit CAGR during 2011-2014. Currently, these markets are characterized by rapid urbanization with a change in lifestyle leading to the growth in prevalence of lifestyle diseases.

Our report has found that China has the largest pharma market out of these seven countries, followed by India, Brazil, and Russia. The maximum growth in future is expected to be in China and India due to strong government support and increasing aging population. Besides, we have identified that the prevalence of chronic diseases will remain one of the major drivers for the pharmaceutical market in the E7 counties. Growing pharma industry in emerging countries are also providing immense opportunity for contract research and manufacturing to flourish at rapid pace.

The research study provides extensive and coherent information about pharma markets in the E7 countries. It highlights several emerging opportunities growing in-line with development of pharma markets in E7 countries. The research study provides detailed statistical and analytical review on demographics, macroeconomic indicators, and disease profile. It contains all the key details that will help clients to draw up market strategies and assess opportunity areas for their success in these emerging pharma markets.

1. Analyst View

2. Research Methodology

3. Global Pharmaceutical Market

3.1 Market Size

3.2 Mature Markets - G7 Countries

3.3 Emerging Markets - E7 Countries

3.4 E7 Countries to Grow Strongly

4. Why E7 Pharmaceutical Market?

4.1 Economic Growth

4.2 Income Level

4.3 Population Base

4.4 Medical & Distribution Infrastructure

4.5 Health Insurance

5. Industry Performance

5.1 Brazil (Past, Present & Future Scenario)

5.1.1 Macroeconomic Indicators

5.1.2 Population Profile

5.1.3 Disease Profile

5.1.4 Healthcare Spending & Financing

5.1.5 Pharmaceutical Market

5.1.6 Import & Export

5.1.7 Branded & Generic Drugs

5.1.8 Key Players

5.2 Russia (Past, Present & Future Scenario)

5.2.1 Macroeconomic Indicators

5.2.2 Population Profile

5.2.3 Disease Profile

5.2.4 Healthcare Spending & Financing

5.2.5 Pharmaceutical Market

5.2.6 Import

5.2.7 Key Players

5.3 India (Past, Present & Future Scenario)

5.3.1 Macroeconomic Indicators

5.3.2 Population Profile

5.3.3 Disease Profile

5.3.4 Healthcare Spending & Financing

5.3.5 Pharmaceutical Market

5.3.6 Import & Export

5.3.7 Branded & Generic Drugs

5.3.8 Key Players

5.4 China (Past, Present & Future Scenario)

5.4.1 Macroeconomic Indicators

5.4.2 Population Profile

5.4.3 Disease Profile

5.4.4 Healthcare Spending & Financing

5.4.5 Pharmaceutical Market

5.4.6 Import & Export

5.4.7 Branded & Generic Drugs

5.4.8 Key Players

5.5 Turkey (Past, Present & Future Scenario)

5.5.1 Macroeconomic Indicators

5.5.2 Population Profile

5.5.3 Disease Profile

5.5.4 Healthcare Spending & Financing

5.5.5 Pharmaceutical Market

5.5.6 Import & Export

5.5.7 Branded & Generic Drugs

5.5.8 Key Players

5.6 Mexico (Past, Present & Future Scenario)

5.6.1 Macroeconomic Indicators

5.6.2 Population Profile

5.6.3 Disease Profile

5.6.4 Healthcare Spending & Financing

5.6.5 Pharmaceutical Market

5.6.6 Import & Export

5.6.7 Branded & Generic Drugs

5.6.8 Key Players

5.7 Indonesia (Past, Present & Future Scenario)

5.7.1 Macroeconomic Indicators

5.7.2 Population Profile

5.7.3 Disease Profile

5.7.4 Healthcare Spending & Financing

5.7.5 Pharmaceutical Market

5.7.6 Import & Export

5.7.7 Branded & Generic Drugs

5.7.8 Key Players

6. Opportunities

6.1 Chronic Diseases

6.2 Pharma Outsourcing Market

6.3 Vaccine Market

7. Restraining Forces

7.1 Counterfeit Drugs

7.2 Patent Protection

7.3 Traditional Medicines

8. Key Players

8.1 GlaxoSmithKline

8.2 Sanofi-Aventis

8.3 Pfizer Inc.

8.4 Novartis

8.5 AstraZeneca

List of Figures:

Figure 3-1: Global - Pharmaceutical Market (Billion US$), 2009-2014

Figure 3-2: G7 Countries - Pharmaceutical Market (Billion US$), 2010

Figure 3-3: G7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014

Figure 3-4: G7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014

Figure 3-5: E7 Countries - Pharmaceutical Market (Billion US$), 2010

Figure 3-6: E7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014

Figure 3-7: E7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014

Figure 3-8: Global - Share of E7 & G7 Countries in Pharmaceutical Market (2010 & 2014)

Figure 4-1: G7 & E7 Countries - Nominal GDP (Trillion US$), 2010 & 2014

Figure 4-2: Global - Share of E7 & G7 Countries Population in Total Population (2010 & 2014)

Figure 4-3: Relative Per Capita Spending on Drugs by Age Group

Figure 5-1: Brazil - Nominal GDP (Billion US$), 2009-2014

Figure 5-2: Brazil - Consumer Price Index (%), 2009-2014

Figure 5-3: Brazil - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-4: Brazil - Population (Million), 2009-2014

Figure 5-5: Brazil - Breakup of Population by Age Group (%), 2009-2014

Figure 5-6: Brazil - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-7: Brazil - Breakup of Deaths by Various Causes (%), 2010

Figure 5-8: Brazil - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-9: Brazil - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-10: Brazil - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-11: Brazil - Pharmaceutical Imports (Billion US$), 2009 & 2010

Figure 5-12: Brazil - Pharmaceutical Exports (Billion US$), 2009 & 2010

Figure 5-13: Brazil - Generic Drugs Market (Billion US$), 2009 & 2010

Figure 5-14: Brazil - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)

Figure 5-15: Russia - Nominal GDP (Billion US$), 2009-2014

Figure 5-16: Russia - Consumer Price Index (%), 2009-2014

Figure 5-17: Russia - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-18: Russia - Population (Million), 2009-2014

Figure 5-19: Russia - Breakup of Population by Age Group (%), 2009-2014

Figure 5-20: Russia - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-21: Russia - Breakup of Deaths by Various Causes (%), 2010

Figure 5-22: Russia - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-23: Russia - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-24: Russia - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-25: Russia - Pharmaceutical Imports (Billion Rubles), 2009 & 2010

Figure 5-26: India - Nominal GDP (Billion US$), 2009-2014

Figure 5-27: India - Consumer Price Index (%), 2009-2014

Figure 5-28: India - Foreign Direct Investment (Billion US$), FY 2009 & FY 2010

Figure 5-29: India - Foreign Direct Investment in Pharmaceutical Market (Million US$), FY 2009 & FY 2010

Figure 5-30: India - Population (Million), 2009-2014

Figure 5-31: India - Breakup of Population by Age Group (%), 2009-2014

Figure 5-32: India - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-33: India - Breakup of Deaths by Various Causes (%), 2010

Figure 5-34: India - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-35: India - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-36: India - Pharmaceutical Market (Billion US$), FY 2009 to FY 2014

Figure 5-37: India - Pharmaceutical Imports (Billion INR), FY 2009 & FY 2010

Figure 5-38: India - Pharmaceutical Exports (Billion INR), FY 2009 & FY 2010

Figure 5-39: India - Breakup of Domestic Pharmaceutical Market by Segment (%), 2010

Figure 5-40: China - Nominal GDP (Billion US$), 2009-2014

Figure 5-41: China - Consumer Price Index (%), 2009-2014

Figure 5-42: China - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-43: China - Population (Million), 2009-2014

Figure 5-44: China - Breakup of Population by Age Group (%), 2009-2014

Figure 5-45: China - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-46: China - Breakup of Deaths by Various Causes (%), 2010

Figure 5-47: China - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-48: China - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-49: China - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-50: China - Pharmaceutical Imports (Billion US$), 2009 & 2010

Figure 5-51: China - Pharmaceutical Exports (Billion US$), 2009 & 2010

Figure 5-52 China - Share of Generic Drugs in Pharmaceutical Market (2010)

Figure 5-53: Turkey - Nominal GDP (Billion US$), 2009-2014

Figure 5-54: Turkey - Consumer Price Index (%), 2009-2014

Figure 5-55: Turkey - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-56: Turkey - Population (Million), 2009-2014

Figure 5-57: Turkey - Breakup of Population by Age Group (%), 2009-2014

Figure 5-58: Turkey - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-59: Turkey - Breakup of Deaths by Various Causes (%), 2010

Figure 5-60: Turkey - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-61: Turkey - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-62: Turkey - Pharmaceutical Market (Billion €), 2009-2014

Figure 5-63: Turkey - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market (2010)

Figure 5-64: Turkey - Pharmaceutical Exports (Million US$), 2009 & 2010

Figure 5-65: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Value (2010)

Figure 5-66: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Volume (2010)

Figure 5-67: Mexico - Nominal GDP (Billion US$), 2009-2014

Figure 5-68: Mexico - Consumer Price Index (%), 2009-2014

Figure 5-69: Mexico - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-70: Mexico - Population (Million), 2009-2014

Figure 5-71: Mexico - Breakup of Population by Age Group (%), 2009-2014

Figure 5-72: Mexico - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-73: Mexico - Breakup of Deaths by Various Causes (%), 2010

Figure 5-74: Mexico - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-75: Mexico - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-76: Mexico - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-77: Mexico - Pharmaceutical Imports (Million US$), 2009 & 2010

Figure 5-78: Mexico - Pharmaceutical Exports (Million US$), 2009 & 2010

Figure 5-79: Mexico - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)

Figure 5-80: Indonesia - Nominal GDP (Billion US$), 2009-2014

Figure 5-81: Indonesia - Consumer Price Index (%), 2009-2014

Figure 5-82: Indonesia - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-83: Indonesia - Population (Million), 2009-2014

Figure 5-84: Indonesia - Breakup of Population by Age Group (%), 2009-2014

Figure 5-85: Indonesia - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-86: Indonesia - Breakup of Deaths by Various Causes (%), 2010

Figure 5-87: Indonesia - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-88: Indonesia - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-89: Indonesia - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-90: Indonesia - Pharmaceutical Exports (Million US$) 2009 & 2010

Figure 5-91: Indonesia - Pharmaceutical Imports (Million US$) 2009 & 2010

Figure 5-92: Indonesia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)

Figure 5-93: Indonesia - Share of Top Players in Prescription Pharmaceutical Market, YTD 12 2010

Figure 5-94: Indonesia - Share of Top Players in OTC Pharmaceutical Market (YTD 12 2010)

List of Tables:

Table 3-1: Global - Pharmaceutical Market by Region (Billion US$), 2010

Table 4-1: E7 Countries - Disposable Income (Million US$), 2010 & 2014

Table 4-2: G7 Countries - Population (Million), 2010 & 2014

Table 4-3: E7 Countries - Population (Million), 2010 & 2014

Table 4-4: G7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014

Table 4-5: E7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014

Table 5-1: Brazil - Share of Top 10 Players in Pharmaceutical Market (2010)

Table 5-2: Russia - Top 10 Pharmaceutical Players by Sales (Million Rubles), 2010

Table 5-3: India - Top 10 Pharmaceutical Players by Sales (Million US$), 2010

Table 6-1: India, China & Brazil - Vaccine Market (Million US$), 2011 & 2013

Table 8-1: GlaxoSmithKline - Strengths & Weaknesses

Table 8-2: Sanofi-Aventis - Strengths & Weaknesses

Table 8-3: Pfizer Inc. - Strengths & Weaknesses

Table 8-4: Novartis - Strengths & Weaknesses

Table 8-5: AstraZeneca - Strengths & Weaknesses

To order this report:

Pharmaceutical Industry: Emerging Pharmaceutical Markets Globally

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis, Inc. to Present at Sidoti & Companys New York II Emerging Growth Institutional Investor Forum
2. Global Trend in Diabetes Could Exact Catastrophic Toll on Emerging Global Healthcare Systems
3. China Biologic Nominated for the 2011 Scrip Award as Best Company in an Emerging Market
4. Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI
5. Emerging Medical Devices Technology Trends - 2011
6. Endoscopy Devices Market in Emerging Economies (India, China, Brazil) - Growing Investments in Hospitals to be the Major Growth Driver
7. ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe
8. Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
9. Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
10. Continuous Glucose Monitors: Evolving Technology, Emerging Opportunities
11. Emerging Pharmaceutical Market in China - Forecast to Become The Worlds Third-Largest Pharmaceutical Market By 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec. 9, 2016  Axovant Sciences Ltd. (NYSE: ... company focused on the treatment of dementia, today ... a Phase 2b trial evaluating treatment with intepirdine ... with donepezil plus placebo in people with mild-to-moderate ... of intepirdine to treatment was associated with reduced ...
(Date:12/8/2016)... -- KEY FINDINGS ... Patient warming and cooling devices offer ... lowering the risks of neurological disorders post cardiac arrests, rapid ... warming systems can be segmented into convective warming system, surface ... the stay at hospitals thus, lowering the healthcare costs by ...
(Date:12/8/2016)... Inc. (NYSE: DPLO) has been recognized by the Detroit Free ... To learn more about Diplomat,s career opportunities, visit ... ... ... a research firm specializing in organizational health and workplace improvement. The ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. ... DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig ... Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference ...
(Date:12/8/2016)... ... 2016 , ... SunView Software aims to redefine IT self-service ... engaging and easy to use. Coming off the heels of a successful launch ... plans to roll out new AI-powered self-service enhancements to help organizations implement effective ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
Breaking Medicine News(10 mins):